Main > A1. CORP. INDEX. O-Om > Ocular Therapeutix Inc./P C2
Ocular Therapeutix Inc./P C2's subsections
2013. 09.19. Cataract Surg.>Sealant
2014. 07.25. IPO
2018. 12.03. FDA APPROVAL
2019. 06.21. FDA APPROVAL
2019. 07.01. USA Launch
2021. 10.11. FDA APPROVAL
2022. 04.13. CN>MACAU Approval
2022. 12.12. Titan Pharma.
Web-Site
Ocular Therapeutix Inc./P C2's products
This section has no products